Abbott to Sell Generic Drug Unit to Mylan for $5.3 Billion

Abbott to Sell Generic Drug Unit to Mylan for $5.3 Billion

JB Reed/Bloomberg

Tablets of Abbott Laboratories' cholesterol drug TriCor sit on display at a pharmacy in New York. Abbott plans to continue to develop and grow the portion of its generic drug business that sells branded generic medicines in emerging markets.